Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Biocon

Tracked across 12 events · 135 articles · First seen Mar 20, 2025 · Last active Sep 22, 2026

Sentiment
9
Attention
6
Events
12
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 20
Business
Impact: Biocon strengthened its leadership team with the appointment of Maninder Kapoor Puri as CHRO and Abhijit Zutshi as CCO, aiming to support its next phase of growth and enhance its global capabilities.
Apr 30, 2026 · 10 articles
4 -40
Business
Impact: Biocon reported a significant decline in consolidated net profit for Q4 FY26 and the full FY26, primarily due to exceptional item outgo, including the impact of a new labor code. Despite this, its revenue from operations increased.
May 08, 2026 · 6 articles
6 20
Business
Impact: Biocon is undergoing a leadership transition with Kiran Mazumdar-Shaw naming Claire Mazumdar as her successor, ensuring continuity and a focus on advanced biotechnology and AI.
May 05, 2026 · 40 articles
2 20
Regulatory
Impact: Biocon received regulatory approval for its Yesintek autoinjector in Canada, strengthening its immunology portfolio and expanding patient access. The approval is positive for Biocon's biosimilar business in Canada.
Jul 29, 2026 · 6 articles
2 40
Business
Biocon, an Indian biopharmaceutical company, signed a partnership agreement with Bahiafarma, a public pharmaceutical laboratory of the State of Bahia, and Bionovis, a Brazilian biotechnology company, to manufacture and commercialize Pertuzumab, a monoclonal antibody for…
Impact: Biocon is the main beneficiary, securing a 10-year supply contract and revenue share in Brazil's public market for Pertuzumab, potentially boosting its biosimilars revenue.
Sep 08, 2026 · 6 articles
4 45
Regulatory
Biopharmaceutical, a wholly-owned subsidiary of Biocon, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Union — European Medicines Agency issued a positive opinion recommending marketing authorisation for its Pertuzumab…
Impact: Parent company of Biopharmaceutical and the primary beneficiary of the CHMP positive opinion, which advances its biosimilar portfolio in Europe and follows its Brazil supply contract.
Sep 21, 2026 · 7 articles
2 -5
Business
Impact: Biocon loses its former CEO S. Siddharth to Syngene, but his departure may be offset by his prior contributions.
Jul 01, 2026 · 6 articles
4 -10
Business
Impact: Biocon's insulin glargine products may face pricing pressure from Awiqli's competitive pricing.
Jul 09, 2026 · 21 articles
4 0
Business
Impact: Biocon's Chairperson and Founder, Kiran Mazumdar-Shaw, participated in the event, aligning the company with the initiative's goals of diversity and inclusion in engineering.
Jun 11, 2026 · 6 articles
2 10
International
Impact: Company founded by Kiran Mazumdar-Shaw, who is involved in the Science Gallery Bengaluru initiative.
Aug 07, 2026 · 12 articles
2 10
Domestic
Impact: Biocon chairperson's participation links the biotech industry to AI skilling.
Sep 05, 2026 · 8 articles
6 0
International
Impact: Biocon was visited by the United States — International Trade Administration delegation to understand AI investments and integration into business models.
Feb 18, 2026 · 7 articles
100 Biocon signed partnership agreement BahiafarmaBiocon Brazil Pertuzumab PDP Deal
100 Biocon signed partnership agreement BionovisBiocon Brazil Pertuzumab PDP Deal
100 Biocon secured 10-year supply contract BrazilBiocon Brazil Pertuzumab PDP Deal
50 Biocon secured 10-year supply contract BrazilBiocon Pertuzumab...
ERGEN INTELLIGENCE
Track Biocon live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.